• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为抗原递送载体的细菌幽灵。

Bacterial ghosts as antigen delivery vehicles.

作者信息

Mayr Ulrike Beate, Walcher Petra, Azimpour Chakameh, Riedmann Eva, Haller Christoph, Lubitz Werner

机构信息

Department of Medical/Pharmaceutical Chemistry, University of Vienna, A-1090 Vienna, Austria.

出版信息

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1381-91. doi: 10.1016/j.addr.2005.01.027. Epub 2005 Apr 20.

DOI:10.1016/j.addr.2005.01.027
PMID:15878634
Abstract

The bacterial ghost system is a novel vaccine delivery system unusual in that it combines excellent natural intrinsic adjuvant properties with versatile carrier functions for foreign antigens. The efficient tropism of bacterial ghosts (BG) for antigen presenting cells promotes the generation of both cellular and humoral responses to heterologous antigens and carrier envelope structures. The simplicity of both BG production and packaging of (multiple) target antigens makes them particularly suitable for use as combination vaccines. Further advantages of BG vaccines include a long shelf-life without the need of cold-chain storage due to their freeze-dried status, they are safe as they do not involve host DNA or live organisms, they exhibit improved potency with regard to target antigens compared to conventional approaches, they are versatile with regards to DNA or protein antigen choice and size, and as a delivery system they offer high bioavailability.

摘要

细菌幽灵系统是一种新型疫苗递送系统,其独特之处在于它将出色的天然固有佐剂特性与对外源抗原的多功能载体功能相结合。细菌幽灵(BG)对抗抗原呈递细胞的高效趋向性促进了对异源抗原和载体包膜结构产生细胞免疫和体液免疫反应。BG生产的简便性以及(多种)靶抗原的包装使其特别适合用作联合疫苗。BG疫苗的其他优点包括:由于其冻干状态,无需冷链储存,保质期长;它们是安全的,因为不涉及宿主DNA或活生物体;与传统方法相比,它们在靶抗原方面表现出更高的效力;在DNA或蛋白质抗原的选择和大小方面具有通用性;作为一种递送系统,它们具有高生物利用度。

相似文献

1
Bacterial ghosts as antigen delivery vehicles.作为抗原递送载体的细菌幽灵。
Adv Drug Deliv Rev. 2005 Jun 17;57(9):1381-91. doi: 10.1016/j.addr.2005.01.027. Epub 2005 Apr 20.
2
Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.利用非活性细菌幽灵载体进行抗原发现及亚单位疫苗递送
Expert Rev Vaccines. 2004 Dec;3(6):681-91. doi: 10.1586/14760584.3.6.681.
3
Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.细菌“幽灵”作为黏膜抗原递送的载体和靶向系统。
Expert Rev Vaccines. 2003 Feb;2(1):45-51. doi: 10.1586/14760584.2.1.45.
4
Bacterial ghosts as adjuvant particles.作为佐剂颗粒的细菌幽灵。
Expert Rev Vaccines. 2007 Apr;6(2):241-53. doi: 10.1586/14760584.6.2.241.
5
Bacterial ghosts: non-living candidate vaccines.细菌幽灵:无生命的候选疫苗。
J Biotechnol. 1996 Jan 26;44(1-3):161-70. doi: 10.1016/0168-1656(95)00123-9.
6
Bacterial ghosts as multifunctional vaccine particles.细菌“幽灵”作为多功能疫苗颗粒。
Behring Inst Mitt. 1997 Feb(98):191-6.
7
Current status and future perspectives of DNA vaccine delivery by attenuated intracellular bacteria.减毒胞内细菌递送DNA疫苗的现状与未来展望
Arch Immunol Ther Exp (Warsz). 2000;48(3):177-82.
8
Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.将抗原通过黏膜疫苗递送至与由食品级细菌制成的佐剂颗粒紧密结合的部位。
Methods. 2006 Feb;38(2):144-9. doi: 10.1016/j.ymeth.2005.09.015.
9
Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.减毒单核细胞增生李斯特菌在体内递送蛋白质抗原或抗原编码DNA和mRNA的不同活疫苗策略的比较。
Infect Immun. 2006 Jul;74(7):3946-57. doi: 10.1128/IAI.00112-06.
10
Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery.细菌幽灵作为一种新型的药物和DNA递送先进靶向系统。
Expert Opin Drug Deliv. 2006 Jan;3(1):11-22. doi: 10.1517/17425247.3.1.11.

引用本文的文献

1
Research progress on vaccines.疫苗的研究进展
Front Vet Sci. 2025 Feb 11;12:1492144. doi: 10.3389/fvets.2025.1492144. eCollection 2025.
2
Advancing vaccine technology through the manipulation of pathogenic and commensal bacteria.通过操纵致病细菌和共生细菌推进疫苗技术。
Mater Today Bio. 2024 Nov 16;29:101349. doi: 10.1016/j.mtbio.2024.101349. eCollection 2024 Dec.
3
Chloramphenicol and gentamicin reduce the evolution of resistance to phage ΦX174 by suppressing a subset of E. coli LPS mutants.氯霉素和庆大霉素通过抑制一部分大肠杆菌脂多糖突变体来减少对噬菌体ΦX174的抗性演变。
PLoS Biol. 2025 Jan 21;23(1):e3002952. doi: 10.1371/journal.pbio.3002952. eCollection 2025 Jan.
4
Development of a therapeutic delivery platform with reduced colonization potential.开发一种具有降低定植潜力的治疗性药物输送平台。
Appl Environ Microbiol. 2024 Nov 20;90(11):e0031224. doi: 10.1128/aem.00312-24. Epub 2024 Oct 31.
5
Delivery of a Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain Using Bacterial Ghosts.使用细菌幽灵递送编码与MHC II类伴侣蛋白恒定链相连的NS3的丙型肝炎病毒疫苗。
Biomedicines. 2024 Feb 26;12(3):525. doi: 10.3390/biomedicines12030525.
6
Comparison of the immune effects of the MOMP antigen displayed in different parts of bacterial ghosts.细菌幽灵不同部位展示的主要外膜蛋白抗原免疫效果的比较。
Front Microbiol. 2024 Feb 7;15:1349746. doi: 10.3389/fmicb.2024.1349746. eCollection 2024.
7
The untapped potential of phage model systems as therapeutic agents.噬菌体模型系统作为治疗剂的未开发潜力。
Virus Evol. 2024 Jan 13;10(1):veae007. doi: 10.1093/ve/veae007. eCollection 2024.
8
Biomimetic and bioinspired nano-platforms for cancer vaccine development.用于癌症疫苗开发的仿生和受生物启发的纳米平台。
Exploration (Beijing). 2023 Apr 25;3(3):20210263. doi: 10.1002/EXP.20210263. eCollection 2023 Jun.
9
Lipid-based nanoparticles for cancer immunotherapy.用于癌症免疫治疗的脂质基纳米颗粒。
Med Rev (2021). 2023 Aug 17;3(3):230-269. doi: 10.1515/mr-2023-0020. eCollection 2023 Jun.
10
The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection.细菌和细菌衍生物作为病毒感染药物传递系统的潜在用途。
Virol J. 2023 Oct 3;20(1):222. doi: 10.1186/s12985-023-02183-z.